Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis

Colorectal cancer remains one of the most frequent malignancies (third place at both genders) worldwide in the last decade, owing to significant changes in modern dietary habits. Approximately half of the patients develop metastases during the course of their disease. The available therapeutic armam...

Descripción completa

Detalles Bibliográficos
Autores principales: Cainap, Calin, Ungur, Rodica Ana, Bochis, Ovidiu-Vasile, Achimas, Patriciu, Vlad, Catalin, Havasi, Andrei, Vidrean, Andreea, Farcas, Anca, Tat, Tiberiu, Gherman, Alexandra, Piciu, Andra, Bota, Madalina, Constantin, Anne-Marie, Pop, Laura Ancuta, Maniu, Dana, Crisan, Ovidiu, Cioban, Cosmin Vasile, Balacescu, Ovidiu, Coza, Ovidiu, Balacescu, Loredana, Marta, Monica Mihaela, Dronca, Eleonora, Cainap, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081186/
https://www.ncbi.nlm.nih.gov/pubmed/33909622
http://dx.doi.org/10.1371/journal.pone.0248922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081186/
https://www.ncbi.nlm.nih.gov/pubmed/33909622
http://dx.doi.org/10.1371/journal.pone.0248922

Ejemplares similares